JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M211711200 on March 7, 2003

J. Biol. Chem., Vol. 278, Issue 22, 19966-19973, May 30, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/22/19966    most recent
M211711200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zargarian, L.
Right arrow Articles by Fermandjian, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zargarian, L.
Right arrow Articles by Fermandjian, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Strategy to Discriminate between High and Low Affinity Bindings of Human Immunodeficiency Virus, Type 1 Integrase to Viral DNA*

Loussinée Zargarian {ddagger}, Mohamed Salah Benleumi {ddagger}, Jean-Guillaume Renisio {ddagger}, Hayate Merad {ddagger}, Richard G. Maroun {ddagger} §, Frédéric Wieber {ddagger}, Olivier Mauffret {ddagger}, Horea Porumb {ddagger}, Frédéric Troalen ¶ and Serge Fermandjian {ddagger} ||

From the {ddagger}Département de Biologie et Pharmacologie Structurales, UMR 8113 CNRS, Institut Gustave Roussy, Villejuif 94805 and Ecole Normale Supérieure de Cachan, Cachan 94235, §Département des Sciences de la Vie et de la Terre, Faculté des Sciences, Université Saint Joseph, CST-Mar Roukos, B.P. 1514, Beyrouth 1107 2050, Liban, and Laboratoire de Microchimie et d'Immunologie Moléculaire, Département de Biologie Clinique, Institut Gustave Roussy, Villejuif 94805, France

The last decade has contributed to our understanding of the three-dimensional structure of the human immunodeficiency virus, type 1 (HIV-1) integrase (IN) and to the description of how the enzyme catalyzes the viral DNA integration into the host DNA. Recognition of the viral DNA termini by IN is sequence-specific, and that of the host DNA does not require particular sequence, although in physicochemical studies IN fails to discriminate between the two interactions. Here, such discrimination was allowed thanks to a model system using designed oligonucleotides and peptides as binding structures. Spectroscopic (circular dichroism, NMR, and fluorescence anisotropy) techniques and biochemical (enzymatic and filter binding) assays clearly indicated that the amphipathic helix {alpha}4, located at the catalytic domain surface, is responsible for the specific high affinity binding of the enzyme to viral DNA. Analogues of the {alpha}4 peptide having increased helicity and still bearing the biologically relevant lysines 156 and 159 on the DNA binding face, and oligonucleotides conserving an intact attachment site, are required to achieve high affinity complexes (Kd of 1.5 nM). Data corroborate previous in vivo results obtained with mutated viruses.


Received for publication, November 18, 2002 , and in revised form, February 3, 2003.

* This work was supported by a grant from SIDACTION. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Département de Biologie et Pharmacologie Structurales (CNRS UMR 8113), PR2, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France. Tel.: 33-0-1-42-11-49-85; Fax: 33-0-1-42-11-52-76; E-mail: sfermand{at}igr.fr.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
J.-G. Renisio, S. Cosquer, I. Cherrak, S. E. Antri, O. Mauffret, and S. Fermandjian
Pre-organized structure of viral DNA at the binding-processing site of HIV-1 integrase
Nucleic Acids Res., April 6, 2005; 33(6): 1970 - 1981.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Lu, A. Limon, H. Z. Ghory, and A. Engelman
Genetic Analyses of DNA-Binding Mutants in the Catalytic Core Domain of Human Immunodeficiency Virus Type 1 Integrase
J. Virol., February 15, 2005; 79(4): 2493 - 2505.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Ikeda, H. Nishitsuji, X. Zhou, N. Nara, T. Ohashi, M. Kannagi, and T. Masuda
Evaluation of the Functional Involvement of Human Immunodeficiency Virus Type 1 Integrase in Nuclear Import of Viral cDNA during Acute Infection
J. Virol., November 1, 2004; 78(21): 11563 - 11573.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Marchand, A. A. Johnson, R. G. Karki, G. C. G. Pais, X. Zhang, K. Cowansage, T. A. Patel, M. C. Nicklaus, T. R. Burke Jr., and Y. Pommier
Metal-Dependent Inhibition of HIV-1 Integrase by {beta}-Diketo Acids and Resistance of the Soluble Double-Mutant (F185K/C280S)
Mol. Pharmacol., September 1, 2003; 64(3): 600 - 609.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.